North America Healthcare Contract Research Organizations (CRO) Services Market

Market Introduction

Healthcare contract research organization generally assists biotechnology, medical device, and pharmaceutical companies in the form of research services outsourced on a contract basis. Secured services include preclinical and clinical testing, clinical research, product development such as drug development or process development such as bioanalytical assay development. These organizations also provide management services such as clinical trial management and pharmacovigilance.

North America Healthcare Contract Research Organizations (CRO) Services Strategic Insights

Strategic insights for the North America Healthcare Contract Research Organizations (CRO) Services provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Healthcare Contract Research Organizations (CRO) Services Report Scope

North America Healthcare Contract Research Organizations (CRO) Services Regional Insights

The geographic scope of the North America Healthcare Contract Research Organizations (CRO) Services refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America healthcare contract research organizations (CRO) services market is to reach US$ 40,863.26 million by 2027 from US$ 19,498.79 million in 2019. The market is anticipated to grow at a CAGR of 9.9% during 2019–2027. Factors such as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. However, stringent regulations for approval of drugs is a major factor hindering the market growth.

Key Market Segments

In terms of service type, the clinical research services segment accounted for the largest share of the North America healthcare contract research organizations (CRO) services market in 2019. Oncology segment accounted for the largest share of the North America healthcare contract research organizations (CRO) services market, by therapeutic indication, in 2019. In terms of end-user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the North America Healthcare contract research organizations (CRO) services market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America healthcare contract research organizations (CRO) services market report are the World Health Organization (WHO), National Institutes of Health (NIH), National Cancer Institute, Centers for Disease Control and Prevention (CDC), Asthma and Allergy Foundation of America (AAFA), and others.

Reasons to buy report

• It provides understanding of the North America, healthcare contract research organizations (CRO) services market landscape and identifies healthcare contract research organizations (CRO) services market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America healthcare contract research organizations (CRO) services market.
• It helps efficiently plan merger and acquisition, and partnership deals in the healthcare contract research organizations (CRO) services market by identifying market segments with the most promising probable sales
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of healthcare contract research organizations (CRO) services market performance of various segments pertaining to the North America healthcare contract research organizations (CRO) services market.
• It provides healthcare contract research organizations (CRO) services market revenue forecast of the market based on various segments for the period from 2019 to 2027.

NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET SEGMENTATION

By Service Type

• Early Phase Development
• Laboratory Services
• Consulting Services
• Clinical Research Services

By Therapeutic Application

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Others

By End-User

• Medical Device Companies
• Pharmaceutical and Biopharmaceutical Companies
• Others (Academic Institutes)

By Country

• US
• Canada
• Mexico

Company Profiles

• Charles River Laboratories, Inc.
• IQVIA INC
• Laboratory Corporation of America Holdings (Covance)
• Parexel International Corporation
• PRA Health Sciences
• Syneos Health
• Medpace
• PPD Inc